1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis: new trials by email Literature Review of Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis trials Research Report on Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis Emapalumab - Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2025-11-12 | 2026-09-09 |
Polyendocrinopathies, Autoimmune (1)
Autoimmune Diseases (1) · Endocrine System Diseases (1) · Immune System Diseases (1)
Emapalumab (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)